Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Gmdx Co. Pty Ltd. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner in 1 distinct art unit. HANEY, AMANDA MARIE is the busiest examiner, with 1 pending matter, so the available activity is concentrated in a single examination channel.
The response can focus directly on the pending biotechnology or pharmaceutical claims and the examiner’s identified issues. Counsel should verify specification support for every proposed amendment and preserve terminology that clearly defines the intended technical distinction. The single assignment allows direct prosecution management without reconciling positions across multiple examiners or art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HANEY, AMANDA MARIE | 1 | 36.5% | +45.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18657581 | METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER | HANEY, AMANDA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18657581 | METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER | HANEY, AMANDA MARIE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18657581 | METHOD FOR DETERMINING THE LIKELIHOOD THAT A SUBJECT HAS OR WILL DEVELOP CANCER | HANEY, AMANDA MARIE | 1682 | §101§112Other | Non-Final OA | — | Pending | May 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGmdx Co. Pty Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Amanda Marie Haney has the most, with 1 of Gmdx Co. Pty Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
